Vitaspring Biomedical VSBC
OTC VSBC
$0.02 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Vitaspring Biomedical (VSBC) Return on Sales [ROS] (2017 - 2022)

Updated

Vitaspring Biomedical (VSBC) recorded Return on Sales [ROS] of 28.22% in fiscal Q3 2023 (quarter ended Oct 31, 2022), down 40.51 percentage points from 68.73% a year earlier and down 5.10 percentage points from the prior quarter.

Analysis

Vitaspring Biomedical (VSBC) Return on Sales [ROS] (2017 - 2022) Analysis & Trends

For FY2022 (ended Jan 31, 2022), Vitaspring Biomedical reported Return on Sales [ROS] of 20.07%, up 191.46 percentage points from FY2021.

  • Annual Return on Sales [ROS] has a four-year change of +59.34 percentage points (FY2018 to FY2022).
  • Across earlier fiscal years, Return on Sales [ROS] came in at -171.39% in FY2021 (-217.09 pp), 45.70% in FY2020 (+176.06 pp), -130.36% in FY2019 (-91.09 pp) and -39.27% in FY2018.
  • Quarterly Return on Sales [ROS] has ranged from -17402.67% in fiscal Q3 2019 to 2631.75% in fiscal Q4 2019 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] rose in six of the last eight quarters, with an average year-over-year change of +896.34 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 17615.70 percentage points in fiscal Q3 2020, against a drop of 17396.48 percentage points in fiscal Q3 2019 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at 33.32% (Q2 2023), 23.03% (Q1 2023) and 40.68% (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Vitaspring Biomedical 4.14 Mn 4.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2022 28.22%
Jul 31, 2022 33.32%
Apr 30, 2022 23.03%
Jan 31, 2022 40.68%
Oct 31, 2021 68.73%
Jul 31, 2021 18.04%
Apr 30, 2021 33.61%
Jan 31, 2021 -139.29%
Oct 31, 2020 -3,021.29%
Jul 31, 2020 -2,282.43%
Apr 30, 2020 -143.95%
Jan 31, 2020 526.86%
Oct 31, 2019 -198.75%
Jul 31, 2019 -302.28%
Apr 30, 2019 -117.95%
Jan 31, 2019 -88.70%
Oct 31, 2018 -17,402.67%
Jul 31, 2018 -584.80%
Apr 30, 2018 39.99%
Jan 31, 2018 -235.82%
API Access

Vitaspring Biomedical Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VSBC&period=max&api_key=YOUR_API_KEY